Unlabeled Use:
Contraindicated in:
Use Cautiously in:
CV: arrhythmias, bradycardia, hypotension.
Derm: facial itching.
EENT: blurred/double vision.
Endo: adrenal insufficiency.
GI: biliary spasm, nausea, vomiting.
MS: skeletal and thoracic muscle rigidity (with rapid IV infusion).
Neuro: confusion, paradoxical excitation/delirium, postoperative drowsiness.
Resp: allergic bronchospasm, APNEA, LARYNGOSPASM, RESPIRATORY DEPRESSION (INCLUDING CENTRAL SLEEP APNEA AND SLEEP-RELATED HYPOXEMIA).
Drug-Drug:
Drug-Food:
Preoperative Use
Adjunct to General Anesthesia
Adjunct to Regional Anesthesia
Postoperative Use (Recovery Room)
General Anesthesia
Sedation/Analgesia
Absorption: Well absorbed after IM administration. IV administration results in complete bioavailability.
Distribution: Extensively distributed to CNS and tissues.
Metabolism/Excretion: Primarily metabolized by the liver via the CYP3A4 isoenzyme; 1025% excreted unchanged by the kidneys.
Half-life: Children: Bolus dose 2.4 hr, long-term continuous infusion 1136 hr; Adults: 24 hr (↑ after cardiopulmonary bypass and in geriatric patients).
NDC Code*